Neonatal Encephalopathy Clinical Trial
Official title:
Long-term Follow-up After Head Cooling for Neonatal Encephalopathy
This observational study will assess long-term functional outcome of survivors from neonatal encephalopathy who were previously treated with either head cooling or with conventional care in a randomized clinical trial. Children's parents will be interviewed by phone by trained staff using the WeeFIM questionnaire to ascertain the childrens' functional performance on a set of skills basic to daily life. This instrument is able to assess a very wide range of abilities, from independently functioning to needing total assistance. The ratings will be used to examine the relationship between the outcome previously measured at 18 months age and functional outcome at school age and to triage the children into those who clearly could not be tested on standardized exams of cognitive functioning, those who potentially could, even if at a low level of cognitive ability, and those who appear to be functioning at an age-appropriate level.
Previous studies have demonstrated that hypothermia for hypoxic-ischemic encephalopathy in the neonatal period is generally safe and feasible, and can improve intermediate term survival without handicap. There is, however, no information on whether cooling improves longer term (school-age) outcomes in non-handicapped survivors. The current observational trial is designed to help obtain additional followup information on children who participated in the initial randomized clinical trial of head-cooling for neonatal encephalopathy. A first step is to collect information on the current status (at 7-8 years of age) of participants in the original study using a standardized telephone questionnaire. This will allow the investigators to more appropriately target children for whom further, more detailed, in-person neurodevelopmental testing would be appropriate. Given limited resources, identification of children for whom such testing would be helpful and instructive is a necessary goal. ;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05471336 -
Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)
|
N/A | |
Recruiting |
NCT05514340 -
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
|
Phase 2 | |
Recruiting |
NCT04603547 -
Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy
|
||
Completed |
NCT01913340 -
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
|
Phase 1/Phase 2 | |
Recruiting |
NCT05772416 -
Neonatal Neurological Examination to Detect Infants at Risk
|
||
Completed |
NCT03122808 -
Uterine Activity in Moderate-Severe Neonatal Encephalopathy: A Case Control Study
|
||
Recruiting |
NCT02544100 -
Neonatal Neurologic Intensive Care Network of China
|
||
Completed |
NCT03380013 -
OMT to Improve Feeding After Hypothermia
|
N/A | |
Active, not recruiting |
NCT03409770 -
Optimising the Duration of Cooling in Mild Encephalopathy
|
N/A | |
Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
Not yet recruiting |
NCT06098833 -
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia
|
Phase 2 | |
Not yet recruiting |
NCT05756296 -
The Long-term Consequences of Neonatal Encephalopathy in the Hypothermia Era
|
||
Recruiting |
NCT04432662 -
Darbepoetin in Neonatal Encephalopathy Trial
|
Phase 2 | |
Recruiting |
NCT02793999 -
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
|
||
Not yet recruiting |
NCT05889507 -
Cooling in Mild Encephalopathy
|
N/A | |
Recruiting |
NCT05848271 -
Natural History Study of Patients With HPDL Mutations
|
||
Not yet recruiting |
NCT04176471 -
TIME Study: Therapeutic Hypothermia for Infants With Mild Encephalopathy
|
N/A | |
Completed |
NCT01309711 -
Magnetic Resonance Biomarkers in Neonatal Encephalopathy
|
||
Recruiting |
NCT04225975 -
Neonate Cerebral Activity in Immediate Post Partum
|
N/A | |
Recruiting |
NCT05610085 -
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
|
Phase 2 |